Barclays Maintains Equal-Weight on Encompass Health, Raises Price Target to $71
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Jason Goldberg maintains an Equal-Weight rating on Encompass Health (NYSE:EHC) and raises the price target from $61 to $71.
August 04, 2023 | 12:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays maintains an Equal-Weight rating on Encompass Health and raises the price target from $61 to $71, which could potentially lead to a positive impact on the stock.
The raised price target by Barclays indicates a positive outlook for Encompass Health. This could potentially lead to an increase in the stock price in the short term as it signals the analyst's increased confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100